Precise incidence rates for bloating specifically are not comprehensively reported in tirzepatide clinical trials, as these symptoms may be captured under broader categories such as "abdominal distension," "dyspepsia," or "abdominal discomfort." However, gastrointestinal adverse events collectively affect a substantial proportion of patients receiving tirzepatide therapy
OTR Health & Wellness is here to help you navigate these challenges
The advancement of dual and multi-receptor agonists, such as tirzepatide, signifies the most recent progression in this therapeutic category, demonstrating enhanced effectiveness in metabolic regulation and weight control
Semaglutide Side Effects Week by Week Week 1 The First Injection Dose: 0.25 mg (sub-therapeutic adaptation only) What to expect: Mild nausea within 2472 hours after injection, especially in the evening Reduced appetite meals feel less interesting Possible mild fatigue or headache Slight constipation or, in some patients, loose stools Injection site mildly tender or red (usually resolves within 24 hours) What this week is NOT: It is not the weight loss week